Drug companies advised to publish unfavourable trial resultsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7400.1163-a (Published 29 May 2003) Cite this as: BMJ 2003;326:1163
- Debashis Singh
New guidelines aimed at increasing transparency and encouraging the responsible and ethical reporting of industry sponsored clinical trials have been published in Current Medical Research and Opinion (2003;19: 149-54), a peer reviewed international journal that focuses on evidence based clinical studies, research investigations, and experimental treatments.
Although not commissioned by the pharmaceutical industry itself, the article presents the first set of guidelines developed by members of the industry (as well as journal editors and academics) for the industry itself.
The “good publication practice” (GPP) guidelines seek greater …